What is Pacific Biosciences of California, Inc.'s Market Cap?

Pacific Biosciences of California, Inc.'s Market Cap is $410.3M, based on as-reported figures from SEC (XBRL) filings.

What is Pacific Biosciences of California, Inc.'s Price / Sales?

Pacific Biosciences of California, Inc.'s Price / Sales is 2.6×, based on as-reported figures from SEC (XBRL) filings.

What is Pacific Biosciences of California, Inc.'s Revenue (TTM)?

Pacific Biosciences of California, Inc.'s Revenue (TTM) is $159.3M, based on as-reported figures from SEC (XBRL) filings.

What is Pacific Biosciences of California, Inc.'s Net Income (TTM)?

Pacific Biosciences of California, Inc.'s Net Income (TTM) is -$131.4M, based on as-reported figures from SEC (XBRL) filings.

What is Pacific Biosciences of California, Inc.'s EBITDA?

Pacific Biosciences of California, Inc.'s EBITDA is $246.1M, based on as-reported figures from SEC (XBRL) filings.

What is Pacific Biosciences of California, Inc.'s Diluted EPS (TTM)?

Pacific Biosciences of California, Inc.'s Diluted EPS (TTM) is -0.42, based on as-reported figures from SEC (XBRL) filings.

What is Pacific Biosciences of California, Inc.'s EBITDA Margin?

Pacific Biosciences of California, Inc.'s EBITDA Margin is 154.5%, based on as-reported figures from SEC (XBRL) filings.

Pacific Biosciences of California, Inc. (PACB) Financial Statements

Pacific Biosciences of California, Inc.

SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS

FIGI BBG001SS9G64

XNAS · usd

1.32▼ 0.03 (-2.22%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close1.35

Day's Range1.30 – 1.36

52-Week Range1.07 – 2.73

Volume4.0M

Avg Volume6.9M

Share Statistics

Shares Outstanding

Employees485

ExchangeXNAS

Listed2010-10-27

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Pacific Biosciences of California, Inc. (PACB)

What is Pacific Biosciences of California, Inc.'s Market Cap?: Pacific Biosciences of California, Inc.'s Market Cap is $410.3M, based on as-reported figures from SEC (XBRL) filings.
What is Pacific Biosciences of California, Inc.'s Price / Sales?: Pacific Biosciences of California, Inc.'s Price / Sales is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Pacific Biosciences of California, Inc.'s Revenue (TTM)?: Pacific Biosciences of California, Inc.'s Revenue (TTM) is $159.3M, based on as-reported figures from SEC (XBRL) filings.
What is Pacific Biosciences of California, Inc.'s Net Income (TTM)?: Pacific Biosciences of California, Inc.'s Net Income (TTM) is -$131.4M, based on as-reported figures from SEC (XBRL) filings.
What is Pacific Biosciences of California, Inc.'s EBITDA?: Pacific Biosciences of California, Inc.'s EBITDA is $246.1M, based on as-reported figures from SEC (XBRL) filings.
What is Pacific Biosciences of California, Inc.'s Diluted EPS (TTM)?: Pacific Biosciences of California, Inc.'s Diluted EPS (TTM) is -0.42, based on as-reported figures from SEC (XBRL) filings.
What is Pacific Biosciences of California, Inc.'s EBITDA Margin?: Pacific Biosciences of California, Inc.'s EBITDA Margin is 154.5%, based on as-reported figures from SEC (XBRL) filings.